Rchr
J-GLOBAL ID:201501014144117309
Update date: Aug. 28, 2022
masahiro hikichi
masahiro hikichi
Affiliation and department:
Research theme for competitive and other funds (1):
- 2019 - 2021 アロマターゼ阻害剤耐性乳がんの持つ分子標的薬抵抗性の克服
Papers (7):
-
Masahiro Hikichi, Yuka Kiriyama, Takanori Hayashi, Kaori Ushimado, Naomi Kobayashi, Makoto Urano, Makoto Kuroda, Toshiaki Utsumi. A hypoglycemia-inducing giant borderline phyllodes tumor secreting high-molecular-weight insulin-like growth factor II: Immunohistochemistry and a western blot analysis. Internal Medicine. 2018. 57. 2. 237-241
-
Hayashi T, Hikichi M, Yukitake J, Wakatsuki T, Nishio E, Utsumi T, Harada N. Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells. Oncotarget. 2018. 9. 34. 23451-23461
-
Takanori Hayashi, Masahiro Hikichi, Jun Yukitake, Nobuhiro Harada, Toshiaki Utsumi. Estradiol suppresses phosphorylation of ER alpha serine 167 through upregulation of PP2A in breast cancer cells. ONCOLOGY LETTERS. 2017. 14. 6. 8060-8065
-
小林尚美, 安藤洋介, 牛窓かおり, 引地理浩, 杉岡篤, 山田成樹, 内海俊明. 再発乳癌患者の薬物療法における薬剤師外来の有用性に関する検討. 藤田学園医学会誌. 2017. 41. 1. 21-23
-
N Kobayashi, M Hikichi, K Ushimado, A Sugioka, Y Kiriyama, M Kuroda, T Utsumi. Differences in subtype distribution between screen-detected and symptomatic inva sive breast cancer and their impact on survival. Clinical and Translational Oncology. 2017
more...
MISC (12):
-
Kobayashi N, Kiriyama Y, Hikichi M, Miyajima S, Kuroda M, Utsumi T. PREDICTIVE SIGNIFICANCE OF BREAST CANCER SUBTYPES IN RESPONSE TO NEOADJUVANT CHEMOTHERAPY. The Breast. 2013. 22. 1. S103
-
Kobayashi N, Hikichi M, Miyajima S, Utsumi T. Subtypes of screen-detected invasive breast cancer and symptomatic invasive breast cancer and their impact on survival. Cancer Research. 2012. 72. 24. Supplement 3:291s
-
Kobayashi N, Ushimado K, Hikichi M, Miyajima S, Utsumi T. Comparison Between Screen-detected Invasive Breast Cancer and Symptomatic Breast Cancer According to Immunohistochemical Intrinsic Subtypes. European Journal of Cancer. 2012. 48. 1. S85
-
Utsumi T, Kobayashi N, Hikichi M, Miyajima S. Predictive Factors for Non-sentinel Lymph Node Metastasis in Breast Cancer Patients with a Positive Sentinel Lymph Node. European Journal of Surgical Oncology. 2012. 38. 9. 816
-
内海俊明, 小林尚美, 宮島慎介, 引地理浩, 牛窓かおり. 術前薬物療法は乳癌手術を縮小させるか】術前ホルモン療法とセンチネルリンパ節生検. 臨床外科. 2011. 66. 7. 886-891
more...
Lectures and oral presentations (67):
-
乳癌術後11年で対側乳房に出現したApocrine carcinomaの一例.
(第15回日本乳癌学会中部地方会 2018)
-
当院におけるエリブリンの肝転移症例に対する有効性の検討.
(第26回日本乳癌学会学術総会 2018)
-
A pilot study to investigate high-sensitivity cardiac troponin I (hscTnI) and high-sensitivity cardiac troponin T (hscTnT) for the prediction of cardiotoxicity in women with breast cancer treated with doxorubicin or trastuzumab.
(4TH ESO-ESMO BREAST CANCER IN YOUNG WOMEN INTERNATIONAL CONFERENCE(BCY4) , 2018. 2018)
-
Clinicopathological features of young women (≤39 years old) with invasive breast cancer.
(THE 11TH EUROPEAN BREAST CANCER CONFERENCE, 2018. 2018)
-
当院における若年性乳癌(stage I-III)の予後と予後規定因子の検討.
(第25回日本乳癌学会学術総会 2017)
more...
Education (2):
- 2011 - 2016 藤田保健衛生大学大学院 医学部 乳腺外科学
- 2000 - 2006 藤田保健衛生大学 医学部 医学科
Professional career (1):
Return to Previous Page